Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Guanadrel production cost?

See the DrugPatentWatch profile for Guanadrel

What is guanadrel, and what production-cost numbers exist?

Guanadrel is a prescription antihypertensive drug (a guanidine derivative). To answer “production cost” in a useful way, it helps to know whether you mean:
- manufacturing cost to make the active pharmaceutical ingredient (API), or
- cost to make a finished dosage form (tablets/capsules), or
- the market price you see for the drug.

With the information provided here, there are no specific, sourced figures for guanadrel’s production cost (API or finished product). Drug manufacturing costs for older, less commonly traded drugs are often not published as a public per-unit estimate.

Why production cost for guanadrel is hard to price

Public “production cost” estimates are uncommon because:
- manufacturers do not disclose per-batch or per-kg cost data publicly,
- costs depend heavily on scale, facility type, yields, solvent use, waste handling, and regulatory quality systems,
- API synthesis routes can vary across suppliers, changing cost drivers materially.

If you’re trying to estimate guanadrel production cost, what inputs matter most?

A workable estimate typically needs at least:
- API synthesis route (number of steps, key intermediates, reagents)
- batch size and yield (overall % yield and step yields)
- solvent and purification needs (chromatography vs crystallization, solvent recovery)
- quality/release testing scope
- regulatory and batch documentation overhead
- finished form packaging and formulation steps (if you mean end-to-end cost)

If you tell me whether you want API cost, finished dose cost, or a market-price comparison, I can outline a more targeted estimation framework.

Could guanadrel be obsolete, discontinued, or limited—affecting cost estimates?

For older generics or drugs with limited demand, “production cost” often becomes disconnected from what you pay. Even if manufacturing cost is relatively low, low volume can raise costs through:
- higher fixed costs per unit,
- supply-chain constraints,
- fewer suppliers and less competition.

What I need from you to give a concrete answer

Reply with one detail and I’ll tailor the answer to what you likely mean by “production cost”:
1) Do you want API (per kg) or finished tablets/capsules (per unit)?
2) What country or market price basis should be used (US/EU/other)?
3) Are you looking for an estimate you can compute, or specific published numbers?

Sources are not available from the provided information. If you share a source link or document that mentions guanadrel cost, I can extract and summarize the relevant numbers.



Other Questions About Guanadrel :

guanadrel price guanadrel cost